Dubai, United Arab Emirates, 22 January 2025: The medical laboratory market in the Middle East and Africa (MEA) is on track for remarkable growth, with recent research projecting it to reach USD473.84 million by 2029 at a robust Compound Annual Growth Rate (CAGR) of 12.6%. Against this promising backdrop, Medlab Middle East, taking place from 3-6 February, will bring together medical laboratory professionals and industry leaders to explore the future of laboratories and their transformative impact on healthcare in the region and beyond.

The medical laboratory market is a crucial part of the healthcare industry, providing a wide range of diagnostic and testing services. Laboratories are vital in disease identification, monitoring and treatment decisions, enabling healthcare practitioners to provide accurate and effective patient care.

The demand for healthcare services in the MEA region has increased considerably in recent years due to a rise in chronic and non-communicable illnesses, a growing population and the implementation of mandatory coverage for healthcare and healthcare insurance programmes.

Also Read : Medlab Middle East 2025 To Highlight The Future Of Laboratory Automation In The MENA Region

“Now in its 24th edition, Medlab Middle East showcases the forefront of laboratory technology and innovation, attracting global leaders, pioneers, and industry experts. The event offers a premier platform for experiencing groundbreaking discoveries, exploring cutting-edge solutions, and engaging in invaluable networking opportunities,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare.

Medical lab technology provides healthcare practitioners with a comprehensive picture of a patient’s health by improving access to health data and providing people more control over their health. These technologies are enabling faster, more accurate and more personalised diagnosis and treatments, reducing costs, increasing accessibility and enhancing patient outcomes.

Leading the way in driving excellence and innovation in medical laboratories, the Medlab Middle East Congress will feature over 150 world-class international and local speakers during an insightful four-day programme. Delivering 12 CME-accredited conference tracks, the Congress will cover Lab Management, Clinical Chemistry, Lab Quality, Haematology, Clinical Microbiology, Molecular Diagnostics, Blood Transfusion Medicine and Cellular Therapy, Histopathology, Lab Automation, Lab Sustainability and Immunology.

Thought Leadership Forums have been added to the Congress agenda this year which are dedicated to Women’s Health and Precision Medicine. On day two and three of Medlab Middle East, the Global Lab Leaders Breakfast Forum will unite advisers, scientific chairs, international partners and stakeholders in an exclusive dialogue to advance laboratory practices worldwide.